An updated review of the effects of eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins on bone preservation
- 7 March 2022
- journal article
- review article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 160, 106630
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Identification and Structure Determination of Novel Anti-inflammatory Mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic AcidJournal of Biological Chemistry, 2012
- Impaired Phagocytosis in Localized Aggressive Periodontitis: Rescue by Resolvin E1PLOS ONE, 2011
- Algal Docosahexaenoic Acid Affects Plasma Lipoprotein Particle Size Distribution in Overweight and Obese AdultsThe Journal of Nutrition, 2011
- Resolvins and protectins: Natural pharmacophores for resolution biologyProstaglandins, Leukotrienes and Essential Fatty Acids, 2010
- An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorptionBritish Journal of Pharmacology, 2008
- Modulation of the Inflammatory Response for Enhanced Bone Tissue RegenerationTissue Engineering Part B: Reviews, 2008
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)Molecular Endocrinology, 2008
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007
- Treating very early rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2006